Harnessing mRNA Therapeutic Platforms to Accelerate Product Development
Time: 2:15 pm
day: Day One Track A PM
Details:
- Describing different platform components from design to manufacturing, and their importance to accelerating product development
- Leveraging critical elements in protein and mRNA design to drive clinically relevant PK and purity behaviours in vivo
- Transitioning from in vitro to rodents to non-human primates to best predict clinical efficacy in heterogeneous populations
